Intrathecal drug therapy: General considerations

Jaroslaw S. Przybyl, Kenneth A. Follett, David Caraway

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Intrathecal drug-delivery systems have been used increasingly for management of pain and spasticity. The indications, efficacy, and cost-effectiveness of intrathecal therapy have not been established with certainty in randomized, controlled trials, but most available data indicate that intrathecal therapy can be a remarkably useful treatment of otherwise intractable pain and spasticity. Outcomes will undoubtedly improve further as we gain a better understanding of (and strict adherence to) patient selection criteria and mechanisms governing intrathecal drug actions while continuing to emphasize thoughtful patient and family education regarding therapeutic goals and their responsibility in helping to make the therapy successful.

Original languageEnglish (US)
Pages (from-to)228-233
Number of pages6
JournalSeminars in Pain Medicine
Volume1
Issue number4
DOIs
StatePublished - Jan 1 2003

Fingerprint

Drug Therapy
Patient Selection
Therapeutics
Intractable Pain
Patient Education
Pain Management
Drug Delivery Systems
Cost-Benefit Analysis
Randomized Controlled Trials
Pharmaceutical Preparations

Keywords

  • Analgesia
  • Drug delivery systems
  • Intrathecal
  • Pain
  • Spasticity

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Intrathecal drug therapy : General considerations. / Przybyl, Jaroslaw S.; Follett, Kenneth A.; Caraway, David.

In: Seminars in Pain Medicine, Vol. 1, No. 4, 01.01.2003, p. 228-233.

Research output: Contribution to journalArticle

Przybyl, Jaroslaw S. ; Follett, Kenneth A. ; Caraway, David. / Intrathecal drug therapy : General considerations. In: Seminars in Pain Medicine. 2003 ; Vol. 1, No. 4. pp. 228-233.
@article{f06113ac3aea44498652bf96abe8a626,
title = "Intrathecal drug therapy: General considerations",
abstract = "Intrathecal drug-delivery systems have been used increasingly for management of pain and spasticity. The indications, efficacy, and cost-effectiveness of intrathecal therapy have not been established with certainty in randomized, controlled trials, but most available data indicate that intrathecal therapy can be a remarkably useful treatment of otherwise intractable pain and spasticity. Outcomes will undoubtedly improve further as we gain a better understanding of (and strict adherence to) patient selection criteria and mechanisms governing intrathecal drug actions while continuing to emphasize thoughtful patient and family education regarding therapeutic goals and their responsibility in helping to make the therapy successful.",
keywords = "Analgesia, Drug delivery systems, Intrathecal, Pain, Spasticity",
author = "Przybyl, {Jaroslaw S.} and Follett, {Kenneth A.} and David Caraway",
year = "2003",
month = "1",
day = "1",
doi = "10.1016/j.spmd.2004.02.004",
language = "English (US)",
volume = "1",
pages = "228--233",
journal = "Seminars in Pain Medicine",
issn = "1537-5897",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - Intrathecal drug therapy

T2 - General considerations

AU - Przybyl, Jaroslaw S.

AU - Follett, Kenneth A.

AU - Caraway, David

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Intrathecal drug-delivery systems have been used increasingly for management of pain and spasticity. The indications, efficacy, and cost-effectiveness of intrathecal therapy have not been established with certainty in randomized, controlled trials, but most available data indicate that intrathecal therapy can be a remarkably useful treatment of otherwise intractable pain and spasticity. Outcomes will undoubtedly improve further as we gain a better understanding of (and strict adherence to) patient selection criteria and mechanisms governing intrathecal drug actions while continuing to emphasize thoughtful patient and family education regarding therapeutic goals and their responsibility in helping to make the therapy successful.

AB - Intrathecal drug-delivery systems have been used increasingly for management of pain and spasticity. The indications, efficacy, and cost-effectiveness of intrathecal therapy have not been established with certainty in randomized, controlled trials, but most available data indicate that intrathecal therapy can be a remarkably useful treatment of otherwise intractable pain and spasticity. Outcomes will undoubtedly improve further as we gain a better understanding of (and strict adherence to) patient selection criteria and mechanisms governing intrathecal drug actions while continuing to emphasize thoughtful patient and family education regarding therapeutic goals and their responsibility in helping to make the therapy successful.

KW - Analgesia

KW - Drug delivery systems

KW - Intrathecal

KW - Pain

KW - Spasticity

UR - http://www.scopus.com/inward/record.url?scp=15944378175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15944378175&partnerID=8YFLogxK

U2 - 10.1016/j.spmd.2004.02.004

DO - 10.1016/j.spmd.2004.02.004

M3 - Article

AN - SCOPUS:15944378175

VL - 1

SP - 228

EP - 233

JO - Seminars in Pain Medicine

JF - Seminars in Pain Medicine

SN - 1537-5897

IS - 4

ER -